210 related articles for article (PubMed ID: 8157211)
21. [Clinical and biological features in refractory anemia with ringed sideroblasts with fluctuant platelet counts].
Ji O; Shen Q; Lin L; Zhang YC; Ji JM; Wu Y; Chen JY; Zhu GR; Kong XT; Xia W; Jiang PJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):1036-41. PubMed ID: 20723324
[TBL] [Abstract][Full Text] [Related]
22. Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome.
Zeigler ZR; Jones D; Rosenfeld CS; Shadduck RK
Stem Cells; 1993 Jan; 11(1):49-55. PubMed ID: 8457781
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and distribution of ringed sideroblasts in primary myelodysplastic syndromes.
Juneja SK; Imbert M; Sigaux F; Jouault H; Sultan C
J Clin Pathol; 1983 May; 36(5):566-9. PubMed ID: 6841648
[TBL] [Abstract][Full Text] [Related]
24. Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis.
Broseus J; Florensa L; Zipperer E; Schnittger S; Malcovati L; Richebourg S; Lippert E; Cermak J; Evans J; Mounier M; Raya JM; Bailly F; Gattermann N; Haferlach T; Garand R; Allou K; Besses C; Germing U; Haferlach C; Travaglino E; Luno E; Pinan MA; Arenillas L; Rozman M; Perez Sirvent ML; Favre B; Guy J; Alonso E; Ahwij N; Jerez A; Hermouet S; Maynadié M; Cazzola M; Girodon F
Haematologica; 2012 Jul; 97(7):1036-41. PubMed ID: 22532522
[TBL] [Abstract][Full Text] [Related]
25. Detection of mi transcription factor (MITF) mRNA in a case of myelodysplastic syndrome and bone marrow mastocytosis.
Wimazal F; Walchshofer S; Baghestanian M; Chott A; Sperr WR; Kopp C; Sillaber C; Semper H; Horny HP; Tröndle U; Födinger M; Schwarzinger I; Lechner K; Valent P
Wien Klin Wochenschr; 1998 Feb; 110(3):79-88. PubMed ID: 9553202
[TBL] [Abstract][Full Text] [Related]
26. Factors influencing leukemic transformation in refractory anemias with excess of blasts, with ringed sideroblasts, and without ringed sideroblasts.
Oguma S; Yoshida Y; Uchino H; Maekawa T
Cancer Res; 1986 Jul; 46(7):3698-700. PubMed ID: 3458528
[TBL] [Abstract][Full Text] [Related]
27. Refractory anemia with ring sideroblasts associated with marked thrombocytosis: case report and literature review.
Găman M; Vlădăreanu AM; Onisai M
Rom J Morphol Embryol; 2012; 53(3):645-50. PubMed ID: 22990561
[TBL] [Abstract][Full Text] [Related]
28. Refractory anemia with ringed sideroblasts and thrombocytosis without JAK2 V617F mutation: report of three cases.
Tatic A; Vasilică M; Coliţă A; Vasilache D; Dobrea C; Jardan C; Găman AM; Crişan AM; Coliţă D; Coriu D
Rom J Morphol Embryol; 2013; 54(4):1177-82. PubMed ID: 24399021
[TBL] [Abstract][Full Text] [Related]
29. Ringed sideroblasts with thrombocytosis: an uncommon mixed myelodysplastic/myeloproliferative disease of older adults.
Shaw GR
Br J Haematol; 2005 Oct; 131(2):180-4. PubMed ID: 16197447
[TBL] [Abstract][Full Text] [Related]
30. RARS with fibrosis and del(20q) transformed into ALL.
Rohr SS; Pelloso LA; Borgo Ados S; de Rezende JG; Silva MR; Yamamoto M; de Lourdes L F Chauffaille M
Med Oncol; 2012 Dec; 29(5):3570-3. PubMed ID: 22760793
[TBL] [Abstract][Full Text] [Related]
31. Cyclosporin A in myelodysplastic syndrome: a preliminary report.
Dixit A; Chatterjee T; Mishra P; Choudhary DR; Mahapatra M; Saxena R; Choudhry VP
Ann Hematol; 2005 Sep; 84(9):565-8. PubMed ID: 15809884
[TBL] [Abstract][Full Text] [Related]
32. [Long-term myelodysplastic syndrome transformed into blastic leukemia].
Dimova R; Apostolov P; Popova L
Vutr Boles; 1988; 27(4):99-103. PubMed ID: 3213032
[TBL] [Abstract][Full Text] [Related]
33. Analysis of leucocyte differentiation antigens in blood and bone marrow in patients with refractory anaemia (RA) and RA with sideroblasts. Prognostic implications of sequential and follow-up data.
Kerndrup G; Bendix-Hansen K; Pedersen B; Ellegaard J; Hokland P
Eur J Haematol; 1988 Oct; 41(4):368-74. PubMed ID: 3197823
[TBL] [Abstract][Full Text] [Related]
34. Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.
Knipp S; Strupp C; Gattermann N; Hildebrandt B; Schapira M; Giagounidis A; Aul C; Haas R; Germing U
Leuk Res; 2008 Jan; 32(1):33-7. PubMed ID: 17412418
[TBL] [Abstract][Full Text] [Related]
35. Immature and mature monocyte-derived dendritic cells in myelodysplastic syndromes of subtypes refractory anemia or refractory anemia with ringed sideroblasts display an altered cytokine profile.
Ma L; Ceuppens J; Kasran A; Delforge M; Boogaerts M; Vandenberghe P
Leuk Res; 2007 Oct; 31(10):1373-82. PubMed ID: 17188353
[TBL] [Abstract][Full Text] [Related]
36. Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations.
Tehranchi R; Fadeel B; Schmidt-Mende J; Forsblom AM; Emanuelsson E; Jadersten M; Christensson B; Hast R; Howe RB; Samuelsson J; Zhivotovsky B; Hellström-Lindberg E
Clin Cancer Res; 2005 Sep; 11(17):6291-9. PubMed ID: 16144933
[TBL] [Abstract][Full Text] [Related]
37. Myelodysplastic syndromes (MDS) in Central Africans.
Mukiibi JM; Paul B
Trop Geogr Med; 1994; 46(1):17-9. PubMed ID: 8165730
[TBL] [Abstract][Full Text] [Related]
38. Development of refractory anemia with ring sideroblasts associated with thrombocytosis from pre-existing refractory anemia with ring sideroblasts through acquisition of Jak2 V617F mutation.
Lu CM; Zhou L; Wang E; Feng S; Sebastian S; Behler C
Leuk Lymphoma; 2011 Dec; 52(12):2405-7. PubMed ID: 21806348
[No Abstract] [Full Text] [Related]
39. Successful allogeneic bone marrow transplantation for childhood-onset refractory anemia with ringed sideroblasts.
Kook H; Kim CJ; Yoon WS; Ryang DW; Hwang TJ
J Korean Med Sci; 2000 Feb; 15(1):103-4. PubMed ID: 10719819
[TBL] [Abstract][Full Text] [Related]
40. [The myelodysplastic syndrome based on our cases].
Bozóky G; Farkas L; Serényi P; Biliczki F
Orv Hetil; 1986 Aug; 127(33):1993-8. PubMed ID: 3466134
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
